Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

被引：0

作者：

Maurizio Fava

Marlene P. Freeman

Martina Flynn

Heidi Judge

Bettina B. Hoeppner

Cristina Cusin

Dawn F. Ionescu

Sanjay J. Mathew

Lee C. Chang

Dan V. Iosifescu

James Murrough

Charles Debattista

Alan F. Schatzberg

Madhukar H. Trivedi

Manish K. Jha

Gerard Sanacora

Samuel T. Wilkinson

George I. Papakostas

机构：

[1] Massachusetts General Hospital,

[2] Baylor College of Medicine/Michael E. Debakey VA Medical Center,undefined

[3] Icahn School of Medicine at Mount Sinai,undefined

[4] Stanford University School of Medicine,undefined

[5] University of Texas Southwestern,undefined

[6] Yale University,undefined

来源：

Molecular Psychiatry | 2020年 / 25卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

引用

页码：1604 / 1604

共 50 条

[41] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Akhondzadeh, Shahin
Tabatabaee, Maryam
Amini, Homayoun
Abhari, Seyed Ali Ahmadi
Abbasi, Seyed Hesamedin
Behnam, Behnaz
[J]. SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
[42] Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial
Hirschmann, S
Dannon, PN
Iancu, I
Dolberg, OT
Zohar, J
Grunhaus, L
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (05) : 556 - 559
[43] BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Marcus, Ronald
Goadsby, Peter J.
Dodick, David
Stock, David
Manos, George
Fischer, Tanya Z.
[J]. CEPHALALGIA, 2014, 34 (02) : 114 - 125
[44] Transcranial magnetic stimulation in treatment-resistant depressed patients: A double-blind, placebo-controlled trial
Rossini, D
Lucca, A
Zanardi, R
Magri, L
Smeraldi, E
[J]. PSYCHIATRY RESEARCH, 2005, 137 (1-2) : 1 - 10
[45] Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W Miskowiak
Maj Vinberg
Ellen M Christensen
Jens D Bukh
Catherine J Harmer
Hannelore Ehrenreich
Lars V Kessing
[J]. Neuropsychopharmacology, 2014, 39 : 1399 - 1408
[46] Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
Goldberg, JF
Burdick, KE
Endick, CJ
[J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 564 - 566
[47] A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression
Patkar, Ashwin A.
Masand, Prakash S.
Pae, Chi-Un
Peindl, Kathleen
Hooper-Wood, Christa
Mannelli, Paolo
Ciccone, Patrick
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (06) : 653 - 656
[48] Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Miskowiak, Kamilla W.
Vinberg, Maj
Christensen, Ellen M.
Bukh, Jens D.
Harmer, Catherine J.
Ehrenreich, Hannelore
Kessing, Lars V.
[J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (06) : 1399 - 1408
[49] Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial
Keshavarzi, Amir
Sharifi, Aziz
Jahangard, Leila
Soltanian, Alireza
Bruehl, Annette Beatrix
Ahmadpanah, Mohammad
Brand, Serge
[J]. NEUROPSYCHOBIOLOGY, 2022, 81 (03) : 192 - 203
[50] Treatment of atypical depression with cognitive therapy or phenelzine - A double-blind, placebo-controlled trial
Jarrett, RB
Schaffer, M
McIntire, D
Witt-Browder, A
Kraft, D
Risser, RC
[J]. ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (05) : 431 - 437

← 1 2 3 4 5 →